Interactive effects of triiodothyronine and androgens on prostate cell growth and gene expression

Endocrinology

Volumn 140, Issue 4, 1999, Pages 1665-1671

  Zhang, Shaobo ^a   Hsieh, Ming Li ^a   Zhu, Wen ^a   Klee, George G ^a   Tindall, Donald J ^a   Young, Charles Y F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; LIOTHYRONINE; MIBOLERONE; POLYCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; THYROID HORMONE;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; GROWTH REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0032982444     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.4.6666     Document Type: Article

References (30)

1. 1. Rajagopal S, Navone NM, Troncoso P, Fritsche HA, Chakrabarty S 1998 Modulation of cellular proliferation and production of prostate-specific antigen and matrix adhesion molecules in human prostate carcinoma cells by polypeptide growth factors: comparative analyses of MDA Pca2a with established cell lines. Int J Oncol 12:589-595
2. 2. Russell PJ, Bennett S, Stricker P 1988 Growth factor involvement in progression of prostate cancer. Clin Chem. 44:705-723
3. 3. Dalkin AC, Gilrain JT, Bradshaw D, Myers CE 1996 Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells. Endocrinology 137:5230-5235
4. 4. Sakurai A, Nakai A, DeGroot LJ 1989 Expression of three forms thyroid hormone receptor in human tissues. Mol Endocrinol 3:392-399
5. 5. Esquenet M, Swinnen JV, Heyns W, Verhoeven G 1995 Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP. Mol Cell Endocrinol 109: 105-111
6. 6. Headland TE, Miller GJ 1994 A serum-free defined medium capable of supporting growth of four established human prostatic carcinoma cell lines. Prostate 24:221-228
7. 7. Henttu P, Vihko P 1992 Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line. J Steroid Biochem Mol Biol 41:349-360
8. 8. Henttu P, Liao SS, Vihko P 1992 Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology 130:766-772
9. 9. Young CYF, Andrews PE, Montgomery BT, Tindall DJ 1992 Tissue-specific and hormonal regulation of human prostate glandular kallikrein. Biochemistry 31:818-324
10. 10. Charlesworth MC, Young CY, Klee GG, Saedi MS, Mikolajczyk SD, Finlay JA, Tindall DJ 1997 Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels. Urology 49:487-493
11. 11. Veldscholte J, Voorhorst-Ogink MM, Bolt-de Vries J, van Rooij HC, Trapman J, Mulder E 1990 Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids. Biochim Biophys Acta 1052:187-194
12. 12. Veldscholte J, Berrevoets CA, Brinkmann AO, Grootegoed JA, Mulder E 1992 Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation. Biochemistry 31:2393-2399
13. 13. Saeed B, Zhang H, Ng SC 1997 Apoptotic program is initiated but not completed in LNCaP cells in response to growth in charcoal-stripped media. Prostate 31:145-152
14. 14. Cory AH, Owen TC, Barltrop JA, Cory JG 1991 Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Comm 3:207-212
15. 15. Grauer LS, Charlesworth MC, Saedi MS, Finlay JA, Liu R-S, Kuus-Reichel K, Young CYF, Tindall DJ 1996 Identification of human glandular kallikrein hK2 from LNCaP cells. J Androl 17:353-359
16. 16. Kumar A, Goel AS, Hill TM, Mikolajczyk SD, Millar LS, Kuus-Reichel K, Saedi MS 1996 Expression of human glandular kallikrein, hK2, in mammalian cells. Cancer Res 56:5397-5402
17. 17. Hsieh M-L, Charlesworth MC, Goodmanson M, Zhang S, Seay T, Klee GG, Tindall DJ, Young CYF 1997 Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D. Cancer Res 57:2651-2656
18. 18. Zhang J, Zhang S, Murtha PE, Zhu W, Hou SS, Young CY 1997 Identification of two novel cis-elements in the promoter of the prostate-specific antigen gene that are required to enhance androgen receptor-mediated transactivation. Nucleic Acids Res 25:3143-3150
19. 19. Young CYF, Andrews PE, Qiu S, Bilhartz DL Tindall DJ 1991 Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res 51:3748-3752
20. 20. Murtha P, Tindall DJ, Young CYF 1993 Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5′ promoter region of the gene. Biochemistry 32:6459-6464
21. 21. Riegman PHJ, Vlietstra RJ, van der Korput JA, Brinkmann AO, Trapman J 1991 The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol Endocrinol 5:1921-1930
22. 22. Blok LJ, E de Ruiter P, Brinkmann AO 1996 Androgen receptor phosphorylation. Endocr Res 22:197-219
23. 23. Van Laar JH, Berrevoets CA, Trapman J, Zegers ND, Brinkmann AO 1991 Hormone-dependent androgen receptor phosphorylation is accompanied by receptor transformation in human lymph node carcinoma of the prostate cells. J Biol Chem 266:3734-3738
24. 24. Muller Y, Rocchi E, Lazaro JB, Clos J 1995 Thyroid hormone promotes BCL-2 expression and prevents apoptosis of early differentiating cerebellar granule neurons. Int J Dev Neurosci 13:871-885
25. 25. Gilchrist CA, Park JH, MacDonald RG, Shull JD 1995 Estradiol and triiodothyronine increase production of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) by GH4C1 rat pituitary tumor cells. Mol Cell Endocrinol 114:147-156
26. 26. Lopez-Barahona M, Fialka I, Gonzalez-Sancho JM, Asuncion M, Gonzalez M, Iglesias T, Bernal J, Munoz A 1995 Thyroid hormone regulates stromelysin expression, protease secretion and the morphogenetic potential of normal polarized mammary epithelial cells. EMBO J 14:1145-1155
27. 27. Zhang S, Mutha PE, Young CY 1997 Defining a functional androgen responsive element in the 5′ far upstream flanking region of the prostate-specific antigen gene. Biochem Biophys Res Commun 231:784-788
28. 28. Zhou Z-X, Lane MV, Kemppainen JA, French FS, Wislon EM 1995 Specificity of ligand-dependent androgen receptor stabilization: receptor domain interaction and receptor stability. Mol Endocrinol 9:208-218
29. 29. Kemppainen JA, Lane MV, Sar M, Wilson EM 1992 Androgen receptor phosphorylation, turnover, nuclear transport and transcriptional activation: specificity for steroids and antihormones. J Biol Chem 267:968-974
30. 30. Krongrad A, Wilson CM, Allman DR, McPaul MJ 1991 Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Mol Cell Endocrinol 76:79-88